Browse Categories

Publications by authors named "Anne Muhleisen"

  • Page 1 of 1
Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.
Clayton English Anne Muhleisen Jose A Rey

P T

April 2017

Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.

View Article and Find Full Text PDF
Privacy Policy Site Map

© LitMetric 2025. All rights reserved.